A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study.
A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study. — المؤلف: Lehmann, Sverre — International journal of chronic obstructive pulmonary disease 20190729
- المؤلف
- Lehmann, Sverre
- النشر
- International journal of chronic obstructive pulmonary disease 20190729
- الوصف
- 199-210 p.
- الموضوعات
- Adrenergic beta-2 Receptor Agonists؛ Adult؛ Aged؛ Biomarkers؛ Bronchodilator Agents؛ Cross-Over Studies؛ Double-Blind Method؛ Drug Combinations